In the reaction of thieno[2,3c]-2-benzothiepin-4(9H)-one (VI) with 1-methyl-4-piperidylmagnesium chloride 7-(1-methyl-4-piperidyl)thieno[2,3-c]-2-benzothiepin-4(9H)-one (VIII) is formed in addition to the expected amino alcohol VII. The title compound I was obtained by the acid catalyzed dehydration of the pure alcohol VII. Compound I (pipethiadene) has outstanding antihistamine, antiserotonin, antireserpine and anticataleptic activity and was recommended to clinical trials as a potential antimigraine agent. For pharmacokinetic and metabolic studies there were prepared the NC2H3 analogue of pipethiadene IV and further, as potential metabolites, the demethyl analogue III, S-oxide X, demethyl S-oxide XI, N-oxide XIII and N,S-dioxide XIV. The Witting reaction of the ketone VI with 3-dimethylaminopropylidenetriphenylphosphorane resulted in a mixture of geometric isomers of 4-(3-dimethylamino-propylidene)-4,9-dihydrothieno[2,3-c]-2-benzothiepin with the strongly predominating Z-isomer XVI which was isolated from the mixture by crystallization of the hydrogen maleate. The mixture with the predominating Z-isomer XVI was converted by the treatment with 80% sulfuric acid and dilution with water to a mixture with the predominating E-isomer XV (dithiadene) which was isolated by crystallization of the hydrogen sulfate. Some further new thieno[2,3-c]-2-benzothiepin derivatives were synthesized as potential intermediates.
在thieno[2,3
c]-2-benzothiepin-4(9
H)-one(
VI)和1-甲基-4-
哌啶基镁氯反应中,除了预期的
氨基醇
VII外,还形成了7-(1-甲基-4-
哌啶基)thieno[2,3-
c]-2-benzothiepin-4(9
H)-one(
VIII)。通过纯醇
VII的酸催化脱
水,得到了标题化合物
I(pipethiadene)。化合物
I具有出色的抗
组胺、抗
血清素、抗
利血平和抗痉挛活性,并被推荐作为潜在的
抗偏头痛药物进行临床试验。为了进行药代动力学和代谢研究,制备了pipethiadene的NC2H3类似物
IV以及作为潜在代谢物的去甲基类似物
III、S-氧化物
X、去甲基S-氧化物
XI、N-氧化物
XIII和N,S-二氧化物
XIV。ketone
VI与3-二甲基
氨基
丙烯基
三苯基膦反应,得到4-(3-二甲基
氨基
丙烯基)-4,9-二氢thieno[2,3-
c]-2-benzothiepin的几何异构体混合物,其中强烈占优势的是
Z-异构体
XVI,通过氢男酸盐结晶从混合物中分离出来。通过80%的
硫酸处理和稀释
水,将占优势的混合物转化为占优势的
E-异构体
XV(dithiadene),并通过
硫酸氢盐结晶分离。还合成了一些新的thieno[2,3-
c]-2-benzothiepin衍
生物作为潜在的中间体。